1. All-cause mortality by treatment group
Kaplan-Meier curves by treatment
group for all-cause mortality of participants
with hospitalized heart failure adjusted for
baseline characteristics of age, race, gender,
smoking, education, treatment of hypertension,
systolic blood pressure, diastolic blood pressure,
pulse, type II diabetes, left ventricular
hypertrophy by ECG, history of coronary heart
disease, body mass index, estimated glomerular
filtration rate, and time to heart failure.
Approximately 92% of participants with hospitalized
(including hospitalized fatal) heart failure
events during ALLHAT were part of the Heart
Failure Validation Study (HFVS). This figure
reflects only those participants with events
meeting the ALLHAT HF definition in the
HFVS17,18 and eligible for extension.
Long-Term Follow-Up of Participants With Heart Failure in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). Piller L et al., Circulation. 2011;124: